The FDA shopped from a menu of aborted fetus organs to insert into lab mice as part of taxpayer-funded experiments, according to government records—a practice that watchdogs said may violate federal law.
From 2012 to 2018, Advanced Bioscience Resources, a nonprofit fetal tissue supplier, charged the FDA $340 per aborted fetus liver and $515 per intact skull. The FDA originally redacted these price listings, but a judge later unsealed the documents containing them, which were made public Tuesday by Judicial Watch. Federal law bans any institution from profiting off the sale of aborted fetuses. Meredith Di Liberto, the lead attorney in the lawsuit to obtain the government records, said the unredacted documents reveal a clear line of business between the FDA and a leading fetal tissue provider.
"I don’t know how you get around that not being a violation of federal law," Di Liberto told the Washington Free Beacon. "Why are they charging per organ? What work is involved that requires you to charge a separate cost for a thymus and a liver?"
The FDA study established human immune systems in mice with aborted fetus organs to test the effectiveness of pre-approved drugs. Scientists made specific requests to the supplier to keep the harvested organs "fresh" and "shipped on wet ice." The agency defended this research saying such organs were procured when research "couldn’t be feasibly achieved through another means."